These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12598334)

  • 21. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
    Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
    J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
    Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
    Saebøe-Larssen S; Fossberg E; Gaudernack G
    BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
    Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
    Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
    Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
    Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
    Wang Y; Kowalski J; Tsai HL; Marik R; Prasad N; Somervell H; Lo PK; Sangenario LE; Dyrskjot L; Orntoft TF; Westra WH; Meeker AK; Eshleman JR; Umbricht CB; Zeiger MA
    Thyroid; 2008 Oct; 18(10):1055-63. PubMed ID: 18816183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
    Raggi CC; Maggi M; Renzi D; Calabrò A; Bagnoni ML; Scaruffi P; Tonini GP; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3866-73. PubMed ID: 11061551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients.
    Chang HH; Tseng YF; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Jeng YM
    Mod Pathol; 2020 Apr; 33(4):531-540. PubMed ID: 31695155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.
    Lincz LF; Mudge LM; Scorgie FE; Sakoff JA; Hamilton CS; Seldon M
    Neoplasia; 2008 Oct; 10(10):1131-7. PubMed ID: 18813352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
    Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
    Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
    Poremba C; Hero B; Heine B; Scheel C; Schaefer KL; Christiansen H; Berthold F; Kneif S; Stein H; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2000 Dec; 35(6):651-5. PubMed ID: 11107139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
    Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
    Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
    Poremba C; Willenbring H; Hero B; Christiansen H; Schäfer KL; Brinkschmidt C; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Ann Oncol; 1999 Jun; 10(6):715-21. PubMed ID: 10442195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
    Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
    Cancer Res; 1998 Sep; 58(18):4168-72. PubMed ID: 9751630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
    Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
    Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.